Particella, Inc.
Particella, Inc. is a preclinical biotechnology company specializing in oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium. Their mission is to develop patient-friendly, repeatable, non-immunogenic oral mRNA medicines that unlock the potential of intestinal delivery.
Industries
biotechnology
genetics
Nr. of Employees
small (1-50)
Particella, Inc.
Products
Oral mRNA delivery platform
A platform technology using orally administered lipid nanoparticles to deliver nucleic acids to the intestinal epithelium for localized therapeutic expression.
Oral mRNA delivery platform
A platform technology using orally administered lipid nanoparticles to deliver nucleic acids to the intestinal epithelium for localized therapeutic expression.
Services
Collaborative preclinical programs to advance oral nucleic acid therapeutics through formulation optimization and in vivo evaluation.
Collaborative preclinical programs to advance oral nucleic acid therapeutics through formulation optimization and in vivo evaluation.
Expertise Areas
- Oral biologics delivery
- Nucleic acid (mRNA) therapeutics
- Nanoparticle drug delivery
- Preclinical development
Key Technologies
- Lipid nanoparticle formulation
- Oral delivery of nucleic acids
- mRNA therapeutics
- Intestinal-targeted delivery